Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€27.00

€27.00

-
-
-
-
 
26.01.26 / Frankfurt WKN: A3DWFC / Name: Indivior / Stock / Pharmaceuticals / Mid Cap / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Indivior plc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Indivior

sharewise wants to provide you with the best news and tools for Indivior, so we directly link to the best financial data sources.

News

What to Know About This Fund's $74.8 Million Indivior Sale: https://cdn.content.foolcdn.com/images/1umn9qeh/production/6f699693a3501babe6eb40aac5d3061bf74bda96-1401x1251.png?w=800&q=75&fit=max&auto=format
What to Know About This Fund's $74.8 Million Indivior Sale

On May 15, 2026, Divisadero Street Capital Management disclosed it sold 2,263,703 shares of Indivior (NASDAQ:INDV), an estimated $74.76 million trade based on quarterly average pricing.

According to

Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%: https://cdn.content.foolcdn.com/images/1umn9qeh/production/cddef4ea39fac2ef3d368e725859ba9ef166511f-1401x1251.png?w=800&q=75&fit=max&auto=format
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%

On May 15, 2026, Madison Avenue Partners disclosed a new position in Indivior (NASDAQ:INDV), acquiring 4,315,162 shares in the first quarter—an estimated $142.51 million trade based on quarterly

Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally: https://cdn.content.foolcdn.com/images/1umn9qeh/production/f5acfa2370b69ef05efd688fbbc9e56e546c0092-1401x1251.png?w=800&q=75&fit=max&auto=format
Why One Fund Made a $23 Million Bet on This Addiction-Treatment Stock Amid a Staggering Rally

On May 11, 2026, Claret Asset Management Corp disclosed a new position in Indivior (NASDAQ:INDV), acquiring 707,267 shares in a trade estimated at $23.36 million based on quarterly average pricing.